The use of dynamic volumetric CT angiography (DV-CTA) for the characterization of endoleaks following fenestrated endovascular aortic aneurysm repair (f-EVAR)  by Bent, Clare L. et al.
CASE REPORTS
The use of dynamic volumetric CT angiography
(DV-CTA) for the characterization of endoleaks
following fenestrated endovascular aortic
aneurysm repair (f-EVAR)
Clare L. Bent, MBBCh, FRCR,a Jeff D. Jaskolka, MD, FRCPC,a Thomas F. Lindsay, MD,b and
Kongteng Tan, FRCS, FRCR, FRCPC,a Toronto, Ontario, Canada
Accurate endoleak classification is essential following fenestrated endovascular aneurysm repair (f-EVAR). Both endoleak
type and exact source of endoleak have implications upon the urgency and complexity of future management strategies.
Herein we report on a patient with a documented endoleak post-f-EVAR, in which the source of blood flow into the
aneurysm sac could not be determined using conventional computed tomographic angiography. Consequently, dynamic
volumetric computed tomographic angiography (DV-CTA) was employed, which clearly illustrated the site of origin of
the endoleak. DV-CTA enables accurate endoleak characterization following f-EVAR, with excellent conspicuity of the
source of blood flow into the aneurysm sac. ( J Vasc Surg 2010;51:203-6.)The technique of fenestrated endovascular aortic aneu-
rysm repair (f-EVAR) has been employed for treatment of
both thoracoabdominal and abdominal aortic aneurysms
with acceptable mid-term clinical outcome.1-3 Fenestrated
EVAR involves insertion of a custom-made device with
fenestrations and branches to accommodate the visceral
branches of the aorta. Through each fenestration or branch,
additional stent grafts are placed to maintain visceral artery
perfusion, while excluding the aortic aneurysm sac. Each
additional stent graft placed increases the number of over-
lapping components and therefore the risk of a junctional
leak. The presence of a junctional leak, known as a type III
endoleak, confers a continued risk of aortic rupture due to
exposure of the aneurysm sac to systemic arterial pressure.
There is a consensus that type III endoleaks require treat-
ment; however, due to the complexity of the custom-made
stent graft implanted, the proximity and overlap of the
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Computed tomographic angiography (CTA) has shown
high sensitivity and specificity in the detection of endoleaks
and is routinely used to follow up patients who have under-
gone conventional stent graft placement.4,5 Despite high
rates of endoleak detection, limited data exist regarding its
use in the characterization of endoleak as a specific type.
Consequently, digital subtraction angiography (DSA) re-
mains the gold standard. However, these procedures can be
challenging in patients with f-EVAR, requiring multiple
arterial puncture sites andmultiple contrast injections while
occluding various branches and/or fenestrations, with con-
sequent high contrast load and radiation dose. Dynamic
volumetric computed tomographic angiography (DV-
CTA) is a novel noninvasive technique that can be em-
ployed to characterize endoleak type and consequently
prescribe appropriate treatment.
This report describes a patient who underwent f-EVAR
and developed an endoleak identified but not accurately
characterized by conventional CTA. Following four-
dimensional (4D) DV-CTA, a type III endoleak was diag-
nosed along with the exact site of origin.
REPORT
A 59-year-old male underwent f-EVAR for a type II
thoracoabdominal aneurysmwith use of a custom-made stent
graft (Cook Inc, Bloomington, Ind). Past medical history
included hypertension and left nephrectomy for benign cystic
renal disease. A left carotid-subclavian artery bypass was per-
formed prior to the procedure during a single anesthetic.
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made device incorporated a fenestrated component with
branches for the celiac and superior mesenteric arteries and
one fenestration for the right renal artery. Stent grafts
placed included a Fluency Plus stent graft (CR Bard,
Tempe, Ariz) with an 18-mm junctional overlap inside the
aortic stent graft branch, reinforced with a Zilver bare metal
stent (Cook Inc) to prevent stent graft kinking, for both the
celiac and superior mesenteric arteries; and a 7-mm-
diameter by 16-mm-length Advanta V12 (Atrium Medical
Corporation, Hudson, NH) balloon-mounted stent graft
flared proximally with a 10-mm-diameter by 20-mm-length
Diamond angioplasty balloon (Boston Scientific Corp,
Natick, Mass) for the right renal artery. Completion angiog-
raphy revealed satisfactory positioning of the components of
the stent graft, with complete exclusion of the aneurysm and
no evidence of endoleak (Fig 1).
Follow-up CTA imaging was performed at 1 month, as
per standard institutional protocol, using a 64 detector CT
scanner (Aquilion 64; Toshiba, Tokyo, Japan). Unen-
hanced images were acquired, followed by arterial phase and
delayed phase images after intravenous injection of iso-
osmolar non-ionic iodinated contrast (Visipaque 270; GE
Healthcare, Milwaukee, Wis). CTA revealed significant
contrast extravasation into the aneurysm sac at the fenes-
trated segment of the stent graft (Fig 2). This was presumed
to represent a type III endoleak, but the exact source of
endoleak could not be determined.
Dynamic volumetric CTA technique. DSA to delin-
eate an endoleak would have been technically challenging
Fig 1. Completion angiography post f-EVAR, focusing on the
visceral segment of the stent graft, demonstrates no evidence of
contrast extravasation. Imaging suggests complete exclusion of the
aneurysm sac. f-EVAR, Fenestrated endovascular aortic aneurysm
repair.in this patient for a number of reasons, including:1. The requirement of more than one arterial puncture to
enable both balloon insertion for branch or fenestration
occlusion during contrast injection and angiographic
catheter insertion to perform DSA.
2. The requirement of a brachial arterial puncture to can-
nulate branches, which are craniocaudal in orientation —
which in turn has an increased risk of postoperative
hematoma and arterial thrombosis.
3. Endoleaks may be of slow flow, making them difficult to
identify.
4. Endoleaks may require multiple projections to detect
their exact source. Consequently, this may lead to high
radiation and contrast doses, in addition to an increased
risk of puncture site complications.
Due to such technical challenges, it was elected to
perform a DV-CTA using a 320 detector CT scanner
(Aquilion One; Toshiba). The scanner has a 16-cm-long
detector, which is capable of scanning in non-helical fash-
ion at a rate of up to three rotations per second.
Initially, 5-mm axial non-contrast images were ac-
quired for localization. This was followed by a low-dose test
bolus to determine contrast medium transit time.
Four-D DV-CTA was performed with a second injec-
tion of 80 mL of contrast at 5 mL/sec, followed by a saline
bolus chase of 30 mL, also at 5 mL/sec. A mask image was
obtained immediately after initiation of contrast injection.
Dynamic scanning was initiated at the time contrast initially
reached the top of the stent graft and continued for a total
of 18 seconds using the following parameters: scan range
16 cm, gantry rotation time 0.5 seconds, tube voltage 120
kVp, tube current 300 mA, and 1-mm section thickness.
Fig 2. Sagittal oblique volume-rendered and axial source CTA
images 1 month post-f-EVAR. Sagittal oblique volume-rendered
CTA from a right-sided projection demonstrates a large endoleak
(white arrowheads) involving the visceral segment of the abdominal
aortic stent graft: celiac artery (CA), superior mesenteric artery
(SMA), and right renal artery (RRA). Exact site of endoleak could
not be identified. Axial source CTA image provides the same infor-
mation.CTA,Computed tomographic angiography; f-EVAR, fenes-
trated endovascular aortic aneurysm repair.The scan was performed with continuous tube activation,
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Postprocessing was completed on the Aquilion One
console and was also transferred to a dedicated post-
processing workstation (Vitrea FX, Vital Images, Minneap-
olis, Minn) for creation of 4D digital subtraction CTA
images as well as 3D and thin-section maximum-intensity
projection cine loops (Figs 3 and 4, Videos 1 and 2).
CTA imaging findings. DV-CTA clearly demon-
strated a type III endoleak originating from the anterior
aspect of the right renal fenestration, likely due to lateral
slippage of the renal stent graft.
Secondary intervention. Following accurate delinea-
tion of endoleak source, it was elected to treat the type III
endoleak via a transfemoral approach. A 6- to 12-mm
diameter by 17-mm-length Jostent stent graft (Jomed;
Abbott Vascular Devices, Rangendingen, Germany) was
hand-crimped onto a 7-mm-diameter by 20-mm-length
Diamond angioplasty baloon (Boston Scientific Corp). The
stent graft was introduced via a 10 F vascular sheath
(Avanti; Cordis Endovascular, Miami, Fla) alongside a 4 F
pigtail catheter to guide stent graft placement and deployed
within the right renal fenestration Advanta V12 stent graft
in situ. Following stent graft deployment, the proximal
Fig 3. Single image from a sagittal oblique volume-rendered cine
loop illustrating extravasation of contrast at the junctional overlap
of the right renal artery (RRA) fenestration and the implanted
Advanta V12 RRA stent graft, indicative of a type III endoleak
(arrowhead). The type III endoleak was thought to be secondary
to lateral slippage of the RRA stent graft. CA, Celiac artery; SMA,
superior mesenteric artery.stent graft was flared using a 10-mm-diameter by 20-mm-length Diamond balloon to ensure adequate seal and pre-
vent migration. Endoleak exclusion was confirmed on sub-
sequent conventional CTA imaging.
DISCUSSION
This case report demonstrates the usefulness of DV-
CTA in classification of endoleaks following f-EVAR. This
is of critical importance as diagnosis frequently dictates the
approach to intervention and also its urgency. Type I and
III endoleaks constitute a major complication requiring
early treatment, as persistent high-pressure perfusion into
the aneurysm sac could potentially lead to aortic rupture.
Endoleaks following conventional EVAR occur in up
to 50% of patients.6-9 Until now, endoleaks observed have
commonly been type I and II. As the utilization of f-EVAR
increases, the risk and incidence of type III endoleak may
rise due to the multinodular nature of these stent grafts.2
At present, conventional CTA continues to be the most
common study performed for endoleak detection in the
follow-up of f-EVAR. Despite its high sensitivity and spec-
ificity, standard CTA protocols have been shown to be
suboptimal for endoleak classification.10 This is in part due
to an inherent limitation of standard CTA, which is a static
image without information about dynamics of flow. The
technique of DV-CTA overcomes this limitation of stan-
dard CTA, allowing imaging of the aneurysm sac in a
continuous fashion, thereby capturing the source of en-
doleak prior to contrast opacification of the aneurysm
sac. Consequently, DV-CTA obviates the need for sup-
plemental invasive investigative techniques, such as an-
giography, necessary to prescribe appropriate treatment.
Potential disadvantages of both CTA and DV-CTA in-
clude exposure to ionizing radiation and the potential
for contrast-induced nephropathy. In addition, this
novel DV-CTA technique requires a 320-detector CT
scanner for its 16-cm field of view dynamic capabilities,
which is the newest-generation CT scanner on the imag-
Fig 4. Single image from 4D dynamic imaging centered at the
level of the right renal artery (RRA) stent graft, showing extrava-
sation of contrast anteriorly depicting a type III endoleak (arrow-
head). SMA, Superior mesenteric artery.ing market, and of limited availability.
JOURNAL OF VASCULAR SURGERY
January 2010206 Bent et alThe use of contrast-enhanced or color-flow duplex
ultrasound (CDU) and time-resolved magnetic resonance
angiography in the classification of endoleaks post-EVAR
have both been investigated.11-13 CDU can accurately
show change in aneurysm size over time but has a low
sensitivity and positive predictive value in endoleak detec-
tion and classification.11,12 Time-resolved magnetic reso-
nance angiography (MRA) has been shown to be an effec-
tive noninvasive method for classification of endoleaks,13
but its use is limited to nitinol-based devices. Since the only
currently available fenestrated stent grafts are manufactured
by Cook Inc, and use a stainless steel skeleton, patients with
f-EVAR cannot be evaluated with MRA.
In conclusion, 4D CTA shows promise as a means of
illustrating the type and source of endoleak in patients with
complex aortic reconstructions, when endoleak origin can-
not be defined by standard CTA imaging. It combines high
spatial and temporal resolution in a single noninvasive
imaging study. Further studies are required to define its
exact role in the follow-up of patients with complex aortic
stent grafts, but in selected cases, it could be extremely
valuable in providing noninvasive information that facili-
tates planning of endoleak management.
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